Birdwatch Note
2023-11-13 13:57:34 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
“phenylephrine” or (PE) in multiple tests dating back to 2017 haven’t shown effectiveness over placebos. More effective as nasal spray. Behind counter options with pseudoephedrine are still available and prove effective. https://www.cbsnews.com/news/nasal-decongestant-phenylephrine-congestion-fda-experts/
Written by 1E3405B5E807A63017FE6B8E890104E4A69541D47463FC459A91D338C4E09F7C
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1723890722988822839
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1724063960176251087
- noteId - 1724063960176251087
- participantId -
- noteAuthorParticipantId - 1E3405B5E807A63017FE6B8E890104E4A69541D47463FC459A91D338C4E09F7C Participant Details
- createdAtMillis - 1699883854322
- tweetId - 1723890722988822839
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- “phenylephrine” or (PE) in multiple tests dating back to 2017 haven’t shown effectiveness over placebos. More effective as nasal spray. Behind counter options with pseudoephedrine are still available and prove effective. https://www.cbsnews.com/news/nasal-decongestant-phenylephrine-congestion-fda-experts/
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-11-13 13:57:34 UTC (1699883854322) |
1969-12-31 23:59:59 UTC (-1) |
2023-11-14 04:08:18 UTC (1699934898456) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-11-13 17:12:31 -0600 | Rating Details | |
| 2023-11-13 16:29:07 -0600 | Rating Details | |
| 2023-11-13 15:35:40 -0600 | Rating Details | |
| 2023-11-13 15:04:59 -0600 | Rating Details | |
| 2023-11-13 14:59:37 -0600 | Rating Details | |
| 2023-11-13 14:37:17 -0600 | Rating Details | |
| 2023-11-13 14:09:04 -0600 | Rating Details | |
| 2023-11-13 13:36:59 -0600 | Rating Details | |
| 2023-11-13 13:01:18 -0600 | Rating Details | |
| 2023-11-13 12:46:36 -0600 | Rating Details | |
| 2023-11-13 12:36:33 -0600 | Rating Details | |
| 2023-11-13 12:34:47 -0600 | Rating Details | |
| 2023-11-13 11:43:48 -0600 | Rating Details | |
| 2023-11-13 11:31:45 -0600 | Rating Details | |
| 2023-11-13 11:18:38 -0600 | Rating Details | |
| 2023-11-13 11:15:12 -0600 | Rating Details | |
| 2023-11-13 11:06:16 -0600 | Rating Details | |
| 2023-11-13 11:04:55 -0600 | Rating Details | |
| 2023-11-13 10:56:37 -0600 | Rating Details | |
| 2023-11-13 10:47:24 -0600 | Rating Details | |
| 2023-11-13 10:38:15 -0600 | Rating Details | |
| 2023-11-13 10:12:31 -0600 | Rating Details | |
| 2023-11-13 10:07:11 -0600 | Rating Details | |
| 2023-11-13 10:05:08 -0600 | Rating Details | |
| 2023-11-13 09:45:46 -0600 | Rating Details | |
| 2023-11-13 09:26:02 -0600 | Rating Details | |
| 2023-11-13 09:24:40 -0600 | Rating Details | |
| 2023-11-13 09:23:43 -0600 | Rating Details | |
| 2023-11-13 09:09:13 -0600 | Rating Details | |
| 2023-11-13 09:07:05 -0600 | Rating Details | |
| 2023-11-13 09:02:09 -0600 | Rating Details | |
| 2023-11-13 09:01:11 -0600 | Rating Details | |
| 2023-11-13 09:00:53 -0600 | Rating Details | |
| 2023-11-13 08:57:21 -0600 | Rating Details | |
| 2023-11-13 08:48:09 -0600 | Rating Details | |
| 2023-11-13 08:45:15 -0600 | Rating Details | |
| 2023-11-13 08:42:08 -0600 | Rating Details | |
| 2023-11-13 08:37:45 -0600 | Rating Details | |
| 2023-11-13 08:35:45 -0600 | Rating Details | |
| 2023-11-13 08:33:48 -0600 | Rating Details | |
| 2023-11-13 08:29:22 -0600 | Rating Details | |
| 2023-11-13 08:27:30 -0600 | Rating Details | |
| 2023-11-13 08:26:59 -0600 | Rating Details | |
| 2023-11-13 08:25:35 -0600 | Rating Details | |
| 2023-11-13 08:24:25 -0600 | Rating Details | |
| 2023-11-13 08:21:41 -0600 | Rating Details | |
| 2023-11-13 08:12:03 -0600 | Rating Details | |
| 2023-11-13 08:11:33 -0600 | Rating Details | |
| 2023-11-13 08:03:30 -0600 | Rating Details | |
| 2023-11-14 17:09:59 -0600 | Rating Details | |
| 2023-11-14 03:02:45 -0600 | Rating Details | |
| 2023-11-13 21:58:21 -0600 | Rating Details | |
| 2023-11-13 20:10:24 -0600 | Rating Details | |
| 2023-11-13 19:43:02 -0600 | Rating Details | |
| 2023-11-13 19:02:30 -0600 | Rating Details | |
| 2023-11-13 18:54:06 -0600 | Rating Details | |
| 2023-11-27 18:49:32 -0600 | Rating Details |